-
Is Covid’s Delta variant putting pressure on Europe’s economic recovery?
News Just as Europe was beginning to open up after months of Covid restrictions, the Delta variant is bringing a third wave of infections. Saloni Sardana looks at what it means for the continent's re-opening plans.
News -
How to pay for the pandemic
Opinion Covid-19 has proved extremely expensive. It’s time to consider fresh sources of government revenue, says Edward Chancellor
Opinion -
Five ways to build Britain's post-pandemic economy
Opinion In Sajid Javid we have a health secretary who cares about livelihoods. This is what he should do, says Matthew Lynn.
Opinion -
Inflation? A Covid relapse? Markets are trying to work out what’s coming next
Opinion Markets have rebounded on the belief that the post-pandemic recovery is real. But things are still very uncertain. Will we see more lockdowns? Persistent inflation? Everlasting stimulus? John Stepek looks at what might lie ahead.
Opinion -
Government support schemes for Covid-hit businesses are coming to an end
Advice Government support schemes to bolster business through the pandemic are ending, despite the extended lockdown
Advice -
Why the government's coronavirus support measures need to change
Opinion Matthew Lynn proposes three ways for the government to help the economy get through lockdown extra time.
Opinion -
How St Ives became St Tropez as the recovery drives prices sky high
Opinion Merryn Somerset Webb finds herself at the epicentre of Britain’s V-shaped recovery as pent-up demand flows straight into Cornwall’s restaurants and beaches.
Opinion -
How rising Covid cases in Asia spell higher inflation in the US
Analysis The Federal Reserve argues that any inflation in the US will be transitory. But that's looking less convincing by the day. And now there's now another factor to consider, says Saloni Sardana. Here, she explains how rising Covid cases in Asia will affect US inflation.
Analysis -
Why Joe Biden’s Big Pharma patent grab is a terrible idea
Briefings The US president has proposed waiving patents on Covid-19 vaccines in a bid to boost global supply. But it won’t work on its own terms and holds dangers for the future.
Briefings
